NEO

SEC source: 0001077183-25-000106 · wk-form4_1747166792.xml · derivative · entry 3

Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,503

Underlying: Common Stock · 6,503 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000106 · wk-form4_1747166792.xml · nonDerivative · entry 2

Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,620

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-25-000106 · wk-form4_1747166792.xml · nonDerivative · entry 1

Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,204

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-25-000105 · wk-form4_1747166756.xml · derivative · entry 3

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,006

Underlying: Common Stock · 13,005 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000105 · wk-form4_1747166756.xml · nonDerivative · entry 2

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,332

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-25-000105 · wk-form4_1747166756.xml · nonDerivative · entry 1

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,499

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-25-000104 · wk-form4_1747166720.xml · derivative · entry 4

Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,613

Underlying: Common Stock · 9,613 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000104 · wk-form4_1747166720.xml · nonDerivative · entry 2

Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,580

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-25-000104 · wk-form4_1747166720.xml · nonDerivative · entry 1

Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,921

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-25-000100 · wk-form4_1746826010.xml · nonDerivative · entry 2

TETRAULT LYNN A. · CIK 0001645512 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Lynn Tetrault Rollover IRA

Disclosed balance after: 7,000

SEC source: 0001077183-25-000098 · wk-form4_1746825886.xml · nonDerivative · entry 1

KANOVSKY STEPHEN M · CIK 0001713090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,090

SEC source: 0001077183-25-000096 · wk-form4_1746735191.xml · nonDerivative · entry 2

Zook Anthony P. · CIK 0001582393 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Amended and Restated Anthony P. Zook Living Trust

Disclosed balance after: 18,900

SEC source: 0001077183-25-000093 · wk-form4_1746648310.xml · nonDerivative · entry 1

Gunn Neil · CIK 0001984436 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,846.31

SEC source: 0001077183-25-000094 · wk-form4_1746648345.xml · nonDerivative · entry 2

Perez David Brian · CIK 0001765355 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Perez Joint Revocable Trust David & Karen Perez TTEE U/A Dated 12/09/2016

Disclosed balance after: 10,000

SEC source: 0001077183-25-000082 · wk-form4_1746475566.xml · nonDerivative · entry 3

Aunan Greg D · CIK 0001646370 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,579

F4 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-25-000082 · wk-form4_1746475566.xml · nonDerivative · entry 2

Aunan Greg D · CIK 0001646370 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,888

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Reflects the release of restricted stock units that were previously reported on a Form 4.

F3 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics, Inc. common stock and is converted into common stock upon vesting.

SEC source: 0001077183-25-000088 · wk-form4_1746562014.xml · nonDerivative · entry 2

Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,308

F3 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-25-000088 · wk-form4_1746562014.xml · nonDerivative · entry 1

Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,762

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects the release of restricted stock units that were previously reported on a Form 4.

F2 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics, Inc. common stock and is converted into common stock upon vesting.

SEC source: 0001077183-25-000090 · wk-form4_1746562124.xml · nonDerivative · entry 1

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,494

F1 · balance_after: This balance includes 1,430 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3.

SEC source: 0001077183-25-000082 · wk-form4_1746475566.xml · nonDerivative · entry 1

Aunan Greg D · CIK 0001646370 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,516

F1 · shares: Shares surrendered to NeoGenomics, Inc. for retirement to satisfy tax obligations in connection with the May 1, 2025 vesting of restricted stock.

SEC source: 0001077183-25-000081 · wk-form4_1746475516.xml · nonDerivative · entry 1

Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,701

F1 · shares: Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the May 1, 2025 vesting of restricted stock.

SEC source: 0001077183-25-000059 · wk-form4_1743710846.xml · derivative · entry 3

Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,687

Underlying: Common Stock · 52,687 shares

Expires not disclosed

F3 · derivative.exercise_date: On April 1, 2025, Mr. Stone was granted 52,687 restricted stock units. These restricted stock units vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000059 · wk-form4_1743710846.xml · derivative · entry 2

Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,518

Underlying: Common Stock · 94,518 shares

Expires 2035-04-01

F1 · derivative.exercise_price: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.

F2 · derivative.exercise_date: On April 1, 2025, Mr. Stone was granted 94,518 stock options. These options vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.

SEC source: 0001077183-25-000058 · wk-form4_1743710801.xml · derivative · entry 3

Zook Anthony P. · CIK 0001582393 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 421,496

Underlying: Common Stock · 421,496 shares

Expires not disclosed

F3 · derivative.exercise_date: On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000058 · wk-form4_1743710801.xml · derivative · entry 2

Zook Anthony P. · CIK 0001582393 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 729,927

Underlying: Common Stock · 729,927 shares

Expires 2035-04-01

F1 · derivative.exercise_price: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.

F2 · derivative.exercise_date: On April 1, 2025, Mr. Zook was granted 729,927 stock options. These options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-25-000042 · wk-form4_1740519619.xml · derivative · entry 5

Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,886

Underlying: Common Stock · 8,443 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: On February 23, 2024, Ms. Harris was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F7 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000042 · wk-form4_1740519619.xml · nonDerivative · entry 2

Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,755

F3 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-25-000042 · wk-form4_1740519619.xml · nonDerivative · entry 1

Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,811

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

F2 · balance_after: This balance includes 548 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan. The shares were acquired in transactions exempt from Section 16b-3.

SEC source: 0001077183-25-000043 · wk-form4_1740519666.xml · derivative · entry 5

Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,886

Underlying: Common Stock · 8,443 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F6 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000043 · wk-form4_1740519666.xml · nonDerivative · entry 2

Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,353

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-25-000043 · wk-form4_1740519666.xml · nonDerivative · entry 1

Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-25-000041 · wk-form4_1740519572.xml · derivative · entry 5

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,886

Underlying: Common Stock · 8,443 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F6 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000041 · wk-form4_1740519572.xml · nonDerivative · entry 2

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,793

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-25-000041 · wk-form4_1740519572.xml · nonDerivative · entry 1

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-25-000040 · wk-form4_1740519501.xml · derivative · entry 5

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,071

Underlying: Common Stock · 15,535 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: On February 23, 2024, Mr. Sherman was granted 46,606 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F7 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000040 · wk-form4_1740519501.xml · nonDerivative · entry 2

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,064

F3 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-25-000040 · wk-form4_1740519501.xml · nonDerivative · entry 1

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,271

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

F2 · balance_after: This balance includes 1,982 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3.

SEC source: 0001077183-25-000039 · wk-form4_1740519447.xml · derivative · entry 3

Smith Christopher M · CIK 0001436707 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,826

Underlying: Common Stock · 57,413 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On February 23, 2024, Mr. Smith was granted 172,239 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000039 · wk-form4_1740519447.xml · nonDerivative · entry 2

Smith Christopher M · CIK 0001436707 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 641,585

F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

SEC source: 0001077183-25-000039 · wk-form4_1740519447.xml · nonDerivative · entry 1

Smith Christopher M · CIK 0001436707 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 655,652

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

SEC source: 0001077183-25-000044 · wk-form4_1740519708.xml · derivative · entry 3

Aunan Greg D · CIK 0001646370 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,971

Underlying: Common Stock · 18,971 shares

Expires not disclosed

F2 · derivative.exercise_date: On February 21, 2025, Mr. Aunan was granted 18,971 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F3 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000044 · wk-form4_1740519708.xml · derivative · entry 2

Aunan Greg D · CIK 0001646370 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,163

Underlying: Common Stock · 31,163 shares

Expires 2035-02-21

F1 · derivative.exercise_date: On February 21, 2025, Mr. Aunan was granted 31,163 stock options. These options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-25-000042 · wk-form4_1740519619.xml · derivative · entry 4

Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,317

Underlying: Common Stock · 84,317 shares

Expires not disclosed

F6 · derivative.exercise_date: On February 21, 2025, Ms. Harris was granted 84,317 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F7 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000042 · wk-form4_1740519619.xml · derivative · entry 3

Harris Melody · CIK 0001880847 · Chf Ops Off, Pres, Informatics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,266

Underlying: Common Stock · 143,266 shares

Expires 2035-02-21

F4 · derivative.exercise_price: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.

F5 · derivative.exercise_date: On February 21, 2025, Ms. Harris was granted 143,266 stock options. These options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-25-000043 · wk-form4_1740519666.xml · derivative · entry 4

Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,238

Underlying: Common Stock · 63,238 shares

Expires not disclosed

F5 · derivative.exercise_date: On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F6 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000043 · wk-form4_1740519666.xml · derivative · entry 3

Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,450

Underlying: Common Stock · 107,450 shares

Expires 2035-02-21

F3 · derivative.exercise_price: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.

F4 · derivative.exercise_date: On February 21, 2025, Ms. Olivo was granted 107,450 stock options. These options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-25-000041 · wk-form4_1740519572.xml · derivative · entry 4

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,317

Underlying: Common Stock · 84,317 shares

Expires not disclosed

F5 · derivative.exercise_date: On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F6 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000041 · wk-form4_1740519572.xml · derivative · entry 3

Stone Warren · CIK 0001955295 · Chief Commerical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,266

Underlying: Common Stock · 143,266 shares

Expires 2035-02-21

F3 · derivative.exercise_price: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.

F4 · derivative.exercise_date: On February 21, 2025, Mr. Stone was granted 143,266 stock options. These options vest ratably over the first three anniversary dates of the grant date.

SEC source: 0001077183-25-000040 · wk-form4_1740519501.xml · derivative · entry 4

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,476

Underlying: Common Stock · 126,476 shares

Expires not disclosed

F6 · derivative.exercise_date: On February 21, 2025, Mr. Sherman was granted 126,476 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F7 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration.

SEC source: 0001077183-25-000040 · wk-form4_1740519501.xml · derivative · entry 3

Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,900

Underlying: Common Stock · 214,900 shares

Expires 2035-02-21

F4 · derivative.exercise_price: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.

F5 · derivative.exercise_date: On February 21, 2025, Mr. Sherman was granted 214,900 stock options. These options vest ratably over the first three anniversary dates of the grant date.